Abstract
The care of patients with breast cancer has become increasingly complex with advancements in diagnostic modalities, surgical approaches, and adjuvant treatments. A multidisciplinary approach to breast cancer care is essential to the successful integration of available therapies. This article addresses the key components of multidisciplinary breast cancer care, with a special emphasis on new and emerging approaches over the past 10 years in the fields of diagnostics, surgery, radiation, medical oncology, and plastic surgery.
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Aromatase Inhibitors / therapeutic use
-
Breast Neoplasms / genetics
-
Breast Neoplasms / pathology
-
Breast Neoplasms / prevention & control
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / therapy*
-
Combined Modality Therapy
-
Fertility
-
Humans
-
Lymph Node Excision
-
Magnetic Resonance Imaging
-
Mammography
-
Mastectomy
-
Mastectomy, Segmental
-
Neoadjuvant Therapy
-
Neoplasm Staging
-
Patient Care Team
-
Patient Selection
-
Plastic Surgery Procedures
-
Positron-Emission Tomography
-
Radiotherapy, Adjuvant
-
Receptor, ErbB-2 / metabolism
-
Selective Estrogen Receptor Modulators / therapeutic use
-
Sentinel Lymph Node Biopsy
-
Tamoxifen / therapeutic use
-
Trastuzumab
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Aromatase Inhibitors
-
Selective Estrogen Receptor Modulators
-
Tamoxifen
-
Receptor, ErbB-2
-
Trastuzumab